Literature DB >> 12395147

Rho/Rho-kinase mediated signaling in physiology and pathophysiology.

Nina Wettschureck1, Stefan Offermanns.   

Abstract

The small GTPase Rho is implicated in many cellular functions such as cell adhesion, cell motility and migration, growth control, cell contraction, and cytokinesis. One of its main effectors, Rho-kinase, appears to play a key role in the regulation of force and velocity of actomyosin crossbridging in smooth muscle and nonmuscle cells by inhibiting myosin phosphatase-mediated dephosphorylation of the regulatory chain of myosin II. Abnormal activation of the Rho/Rho-kinase pathway has been shown to play a role in diseases such as hypertension and bronchial asthma. This review summarizes the current knowledge on the physiological and pathophysiological function of the Rho/Rho-kinase mediated pathway in various tissues with a focus on its possible role as a target for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395147     DOI: 10.1007/s00109-002-0370-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  91 in total

1.  Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors.

Authors:  Rand Shahin; Saja Alqtaishat; Mutasem O Taha
Journal:  J Comput Aided Mol Des       Date:  2011-12-14       Impact factor: 3.686

2.  RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells.

Authors:  Yinghui Fu; Jian Huang; Ke-Sheng Wang; Xin Zhang; Ze-Guang Han
Journal:  Mol Biol Rep       Date:  2010-04-06       Impact factor: 2.316

3.  In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.

Authors:  Kwang-Hoon Chun; Kang-Duk Choi; Dae-Ho Lee; Yoonshin Jung; Robert R Henry; Theodore P Ciaraldi; Young-Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

4.  C2-ceramide induces vasodilation in phenylephrine-induced pre-contracted rat thoracic aorta: role of RhoA/Rho-kinase and intracellular Ca2+ concentration.

Authors:  Gil-Jin Jang; Duck Sun Ahn; Young-Eun Cho; Kathleen G Morgan; Young-Ho Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-18       Impact factor: 3.000

5.  Expression of RhoA in placenta of preeclampsia.

Authors:  Li Zhou; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

6.  Newborn lamb coronary artery reactivity is programmed by early gestation dexamethasone before the onset of systemic hypertension.

Authors:  Robert D Roghair; Jeffrey L Segar; Ram V Sharma; Matthew C Zimmerman; D K Jagadeesha; Emily M Segar; Thomas D Scholz; Fred S Lamb
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

Review 7.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

8.  Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin.

Authors:  Jing Feng; Bao-yuan Chen; Lin-yang Cui; Bao-li Wang; Chun-xia Liu; Pan-feng Chen; Mei-nan Guo; Li-xia Dong; Shuo Li
Journal:  Sleep Breath       Date:  2009-03-17       Impact factor: 2.816

9.  H-1152 effects on intraocular pressure and trabecular meshwork morphology of rat eyes.

Authors:  Man Yu; Xiaoming Chen; Ningli Wang; Suping Cai; Ni Li; Jinghua Qiu; Curtis R Brandt; Paul L Kaufman; Xuyang Liu
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

10.  Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction.

Authors:  Dedmer Schaafsma; Reinoud Gosens; I Sophie T Bos; Herman Meurs; Johan Zaagsma; S Adriaan Nelemans
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.